493 related articles for article (PubMed ID: 26109530)
1. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
Lemoine M; Shimakawa Y; Nayagam S; Khalil M; Suso P; Lloyd J; Goldin R; Njai HF; Ndow G; Taal M; Cooke G; D'Alessandro U; Vray M; Mbaye PS; Njie R; Mallet V; Thursz M
Gut; 2016 Aug; 65(8):1369-76. PubMed ID: 26109530
[TBL] [Abstract][Full Text] [Related]
2. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
3. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
4. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
5. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
6. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
Li Q; Lu C; Li W; Huang Y; Chen L
J Viral Hepat; 2017 Dec; 24(12):1143-1150. PubMed ID: 28685907
[TBL] [Abstract][Full Text] [Related]
7. Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.
Luo J; Du Z; Liang D; Li M; Yin Y; Chen M; Yang L
J Clin Lab Anal; 2022 Aug; 36(8):e24596. PubMed ID: 35808928
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
9. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
Yue W; Li Y; Geng J; Wang P; Zhang L
Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
[TBL] [Abstract][Full Text] [Related]
11. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.
Lee J; Kim MY; Kang SH; Kim J; Uh Y; Yoon KJ; Kim HS
Br J Biomed Sci; 2018 Jul; 75(3):128-132. PubMed ID: 29893189
[TBL] [Abstract][Full Text] [Related]
12. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
13. Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?
Desalegn H; Aberra H; Berhe N; Gundersen SG; Johannessen A
Liver Int; 2017 Oct; 37(10):1461-1467. PubMed ID: 28222249
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
15. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
[TBL] [Abstract][Full Text] [Related]
16. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease.
Li Q; Huang C; Xu W; Hu Q; Chen L
Medicine (Baltimore); 2020 Jun; 99(23):e20616. PubMed ID: 32502037
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.
Huang R; Wang G; Tian C; Liu Y; Jia B; Wang J; Yang Y; Li Y; Sun Z; Yan X; Xia J; Xiong Y; Song P; Zhang Z; Ding W; Wu C
Sci Rep; 2017 Aug; 7(1):8543. PubMed ID: 28819319
[TBL] [Abstract][Full Text] [Related]
19. Optimized cutoffs of gamma-glutamyl transpeptidase-to-platelet ratio, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 scoring systems for exclusion of cirrhosis in patients with chronic hepatitis B.
Liu X; Li H; Wei L; Tang Q; Hu P
Hepatol Commun; 2022 Jul; 6(7):1664-1672. PubMed ID: 35312182
[TBL] [Abstract][Full Text] [Related]
20. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
